Cargando…

Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease

Parkinson's disease (PD) is a common neurodegenerative disorder, which is characterized by the selective and progressive death of dopaminergic (DA) neurons in the substantia nigra. Increasing evidence suggests that inflammation is important in the degeneration of DA neurons. The purinergic rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xin-Hong, Xie, Xin, Luo, Xiao-Guang, Shang, Hong, He, Zhi-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364844/ https://www.ncbi.nlm.nih.gov/pubmed/28035410 http://dx.doi.org/10.3892/mmr.2016.6070

Ejemplares similares

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
por: Couch, Yvonne, et al.
Publicado: (2011)

Brilliant Blue Dyes in Daily Food: How Could Purinergic System Be Affected?
por: Ferreira, Leonardo Gomes Braga, et al.
Publicado: (2016)

Brilliant blue G attenuates lipopolysaccharide-mediated microglial activation and inflammation☆
por: Lu, Kui, et al.
Publicado: (2013)

Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease
por: Droguerre, Marine, et al.
Publicado: (2022)

Anti-Prion Activity of Brilliant Blue G
por: Iwamaru, Yoshifumi, et al.
Publicado: (2012)

Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection
por: Li, Da-Wei, et al.
Publicado: (2019)

Brilliant Blue G assisted Epiretinal Membrane Surgery
por: Totan, Yüksel, et al.
Publicado: (2014)

Neuroprotective Effects of an Edible Pigment Brilliant Blue FCF against Behavioral Abnormity in MCAO Rats
por: Le, Jingyang, et al.
Publicado: (2022)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
por: Boi, Laura, et al.
Publicado: (2020)

Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
por: Machado, A., et al.
Publicado: (2011)

Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide
por: He, Huan, et al.
Publicado: (2016)

Retinal Biocompatibility of Brilliant Blue G with Deuterated Water for Chromovitrectomy
por: Badaró, Emmerson, et al.
Publicado: (2014)

Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
por: Bartok, Melinda, et al.
Publicado: (2015)

Use of Brilliant Blue G in Descemet's Membrane Endothelial Keratoplasty
por: Hayashi, Takahiko, et al.
Publicado: (2017)

Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
por: Dakik, Hassan, et al.
Publicado: (2021)

Intranigral Injection of Endotoxin Suppresses Proliferation of Hippocampal Progenitor Cells
por: Darwish, Batoul, et al.
Publicado: (2019)

Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-α Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration
por: Ma, Min, et al.
Publicado: (2014)

New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery
por: Spadaro, Angelo, et al.
Publicado: (2020)

Adsorption of Methylene Blue, Bromophenol Blue, and Coomassie Brilliant Blue by α-chitin nanoparticles
por: Dhananasekaran, Solairaj, et al.
Publicado: (2016)

Selection of Ovine Oocytes by Brilliant Cresyl Blue Staining
por: Wang, Liqin, et al.
Publicado: (2012)

Flunitrazepam overdose induces brilliant‐blue gastric fluid
por: Yamagishi, Toshinobu, et al.
Publicado: (2017)

Metabolomics Fingerprint Induced by the Intranigral Inoculation of Exogenous Human Alpha-Synuclein Oligomers in a Rat Model of Parkinson’s Disease
por: Murgia, Federica, et al.
Publicado: (2020)

Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket
por: Bin Dayel, Anfal, et al.
Publicado: (2019)

CERTAIN EFFECTS OF SALTS ON THE PENETRATION OF BRILLIANT CRESYL BLUE INTO NITELLA
por: Irwin, Marian
Publicado: (1927)

Bio-bleaching of Remazol brilliant blue-19 by Stereum ostrea
por: Praveen, K., et al.
Publicado: (2015)

Long-Term Evaluation of Intranigral Transplantation of Human iPSC-Derived Dopamine Neurons in a Parkinson’s Disease Mouse Model
por: Brot, Sébastien, et al.
Publicado: (2022)

Evaluation of the Anticonvulsant Effect of Brilliant Blue G, a Selective P2X7 Receptor Antagonist, in the iv PTZ-, Maximal Electroshock-, and 6 Hz-Induced Seizure Tests in Mice
por: Nieoczym, Dorota, et al.
Publicado: (2017)

Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats
por: Pereira, José Monteiro Sad, et al.
Publicado: (2020)

Brilliant blue G-assisted peeling of the internal limiting membrane in macular hole surgery
por: Naithani, Prashant, et al.
Publicado: (2011)

Interaction of Bioactive Coomassie Brilliant Blue G with Protein: Insights from Spectroscopic Methods
por: Katrahalli, Umesha, et al.
Publicado: (2010)

Brilliant blue G attenuates neuro-inflammation via regulating MAPKs and NF-κB signaling pathways in lipopolysaccharide-induced BV2 microglia cells
por: Wang, Wei, et al.
Publicado: (2020)

Selective Voltammetric Sensor for the Simultaneous Quantification of Tartrazine and Brilliant Blue FCF
por: Gimadutdinova, Liliya, et al.
Publicado: (2023)

Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in postoperative ileus
por: KIMURA, Hitomi, et al.
Publicado: (2022)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Brilliant Blue G Inhibits Inflammasome Activation and Reduces Disruption of Blood–Spinal Cord Barrier Induced by Spinal Cord Injury in Rats
por: Zhou, Xin, et al.
Publicado: (2019)

Brilliant
por: Dykes, Mervyn
Publicado: (2005)

Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission
por: Shinozaki, Youichi, et al.
Publicado: (2014)

The Effect of Brilliant Blue-Based Plaque-Staining Agents on Aesthetic Orthodontic Appliances
por: Topolska, Justyna, et al.
Publicado: (2021)

Efficacy of Fungi in the Decolorization and Detoxification of Remazol Brilliant Blue Dye in Aquatic Environments
por: , Nabeela, et al.
Publicado: (2023)

Enhanced Reactive Brilliant Blue Removal Using Chitosan–Biochar Hydrogel Beads
por: Zhao, Yangyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dqup5b4j8va020tiieommf1bec